Kinaset Therapeutics
Manufacturing · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.kinasettx.comRevenue
<$5 MillionIndustry
About Kinaset Therapeutics
Kinaset Therapeutics Org Chart
Is Kinaset Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Kinaset Therapeutics is spiking on competitors!
Product Launch: Get notified when Kinaset Therapeutics launches new products
Check if Kinaset Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Kinaset Therapeutics has new funding data
Kinaset Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Kinaset Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Kinaset Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Kinaset Therapeutics had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Kinaset Therapeutics
Find 2 more new buyers
Company Profile Activity
Activity Insights
Kinaset Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Kinaset Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Kinaset Therapeutics.
Kinaset Therapeutics Tech Stack
A closer look at the technologies used by Kinaset Therapeutics
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kinaset Therapeutics
Kinaset Therapeutics is focused on developing inhaled therapeutics for respiratory diseases, specifically targeting severe asthma with their product KN-002. This innovative treatment aims to address all patients with severe asthma, regardless of the underlying cause of inflammation. The noninvasive approach allows for convenient inhalation, deliver... Read More